Medicine

The monoclonal antibody will be available to people 65+, or with underlying health conditions. Supplies will be short and distributing the medicine fairly will be difficult.

This week: COVID update in Philadelphia, what the rollout of legal pot will look like in NJ, and jazz musician Micah Graves.

The shots made by Pfizer and its German partner BioNTech are among 10 possible vaccine candidates in late-stage testing around the world.

Not even a year after SARS-CoV-2 was first identified, several coronavirus vaccines are now in the final stages of testing. Some people w ...

According to the NFL Network’s Tom Pelissero, the player is Eagles safety Marcus Epps. The team says the player went into self-isolation.

We discuss how the U.S. pandemic response get derailed and ways to stay safe and sane this winter as Covid rates rise.

The agency, also known as the United Nations Children's Fund, plans to distribute up to 1 billion syringes by 2021.

The vaccine cold chain hurdle is the latest disparity of the pandemic weighted against the poor, who more often live and work in conditions that allow the virus to spread.

Health officials are urging people to get the flu shot so that doctors and hospitals don’t face the extra strain of having to treat influenza in the midst of the pandemic.

Fewer patient visits, delayed or reduced insurance reimbursements, and the coronavirus itself struck a blow at some offices — and the communities they serve.

The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.

Even before President Trump received the drug remdesivir to help treat his case of COVID-19, Pennsylvania Treasurer Joe Torsella was raising alarms about the price of the drug

A growing, bipartisan chorus of lawmakers, experts and public health officials says the country is ill prepared for a projected winter surge of COVID-19.

'Our current political leaders have demonstrated that they are dangerously incompetent," the medical journal's editors say in a scathing editorial.

The drug, Remdesivir, emerged in part because researchers had previously tested it in China through a project whose grant was abruptly ended by the NIH.